Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

被引：4
作者：
Duerr, Donat [1 ]
Siciliano, Raffaele Daniele [1 ]
Hummel, Yvonne [1 ]
O'Meara, Alix [1 ]
Hirschi, Anita [1 ]
Burkhard, Roger [1 ]
Honegger, Hanspeter [1 ]
机构：
[1] Stadtspital Triemli, CH-8063 Zurich, Switzerland
来源：
ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 01期
关键词：
DELETION; MANAGEMENT; DEL(5Q);
D O I：
10.1007/s00277-009-0775-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 42 条
  • [21] Myelodysplastic disorders carrying both isolated del(5q) and JAK2V617F mutation: concise review, with focus on lenalidomide therapy
    Musto, Pellegrino
    Simeon, Vittorio
    Guariglia, Roberto
    Bianchino, Gabriella
    Grieco, Vitina
    Nozza, Filomena
    La Rocca, Francesco
    Marziano, Gioacchino
    Lalinga, Anna Vittoria
    Fabiani, Emiliano
    Voso, Maria Teresa
    Scaravaglio, Patrizia
    Mecucci, Cristina
    D'Arena, Giovanni
    ONCOTARGETS AND THERAPY, 2014, 7 : 1043 - 1050
  • [22] Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or-7/del(7q)
    Zhang, Rui
    Kim, Young-Mi
    Wang, Xianfu
    Li, Yan
    Lu, Xianglan
    Sternenberger, Andrea R.
    Li, Shibo
    Lee, Ji-Yun
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2015, 12 (09): : 719 - 726
  • [23] Interphase FISH Does Not Improve the Detection of DEL(5q) and DEL(20q) in Myelodysplastic Syndromes
    Douet-Guilbert, Nathalie
    Herry, Angele
    Le Bris, Marie-Josee
    Gueganic, Nadia
    Bovo, Clement
    Morel, Frederic
    De Braekeleer, Marc
    ANTICANCER RESEARCH, 2011, 31 (03) : 1007 - 1010
  • [24] The Heterogeneous Prognosis of Patients With Myelodysplastic Syndrome and Chromosome 5 Abnormalities How Does It Relate to the Original Lenalidomide Experience in MDS?
    Kantarjian, Hagop
    O'Brien, Susan
    Ravandi, Farhad
    Borthakur, Gautam
    Faderl, Stefan
    Bueso-Ramos, Carlos
    Abruzzo, Lynne
    Pierce, Sherry
    Shan, Jianqin
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    CANCER, 2009, 115 (22) : 5202 - 5209
  • [25] Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide
    Park, S.
    Vassilieff, D.
    Bardet, V.
    Viguie, F.
    Dreyfus, F.
    LEUKEMIA, 2010, 24 (11) : 1960 - 1962
  • [26] Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
    Sugimoto, Yuka
    Sekeres, Mikkael A.
    Makishima, Hideki
    Traina, Fabiola
    Visconte, Valeria
    Jankowska, Anna
    Jerez, Andres
    Szpurka, Hadrian
    O'Keefe, Christine L.
    Guinta, Kathryn
    Afable, Manuel
    Tiu, Ramon
    McGraw, Kathy L.
    List, Alan F.
    Maciejewski, Jaroslaw
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [27] Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance Study
    Poloni, Antonella
    Raaschou-Jensen, Klas
    Mohedo, Francisca Hernandez
    Paolini, Stefania
    Oliva, Esther Natalie
    Buccisano, Francesco
    Vasconcelos, Alberto
    Kim, Iris
    Makwana, Aidan
    Bernasconi, David
    Rosettani, Barbara
    Prebet, Thomas
    Santini, Valeria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (03) : e131 - e142
  • [28] The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities
    Gurney, Mark
    Patnaik, Mrinal M.
    Hanson, Curtis A.
    Litzow, Mark R.
    Al-Kali, Aref
    Ketterling, Rhett P.
    Tefferi, Ayalew
    Gangat, Naseema
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (01) : 57 - 60
  • [29] Detection of chromosome 5q interstitial deletion of 5q14.3-q31.1 by chromosome microarray analysis in a second-trimester fetus with multiple congenital anomalies and a literature review of chromosome 5q interstitial deletion syndrome
    Chen, Chih-Ping
    Huang, Jian-Pei
    Wu, Fang-Tzu
    Wu, Peih-Shan
    Pan, Yen-Ting
    Wang, Wayseen
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (06): : 918 - 921
  • [30] TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
    Jaedersten, Martin
    Saft, Leonie
    Smith, Alexander
    Kulasekararaj, Austin
    Pomplun, Sabine
    Goehring, Gudrun
    Hedlund, Anette
    Hast, Robert
    Schlegelberger, Brigitte
    Porwit, Anna
    Hellstrom-Lindberg, Eva
    Mufti, Ghulam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1971 - 1979
12345